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Neutrophils are immune defenders. In this paper, Kawano et al. show that, by 
producing prostaglandin E2 (PGE2), they also regulate hematopoietic stem cell 
mobilization and cause fever 1. 
 
The bone marrow is home to hematopoietic stem and progenitor cells (HSPC) and their 
descendants. Continued production of all blood lineages requires a structured 
organization and complex interactions among the many cell types that reside in this 
organ. Among these cell types, early studies identified osteoblastic cells that line the 
endosteal surface as important components of the hematopoietic niche, whereas 
macrophages and other cells of hematopoietic origin have only been recognized as 
regulators of the bone marrow niche in recent years 2. Sympathetic nerves and 
mesenchymal progenitors are also regulators of the HSPC niche, and current efforts in 
the field aim to understand how all these very different cellular elements coordinate to 
preserve bone marrow homeostasis. 
Transient disorganization of the cellular niche network may be important when the 
bone marrow needs to supply a surplus of defensive immune cells in response to a 
stress. For example, during acute infections endothelial cells respond by producing 
large amounts of the cytokine granulocyte colony-stimulating factor, or G-CSF 3. On 
one hand, this cytokine accelerates production of neutrophils (i.e., granulopoiesis), the 
genuine anti-microbial defenders; on the other hand, G-CSF initiates a cascade of 
events within the bone marrow that disrupts niche activity and leads to the release of 
HSPC into the bloodstream. Hematologists appreciated the therapeutic potential of 
using G-CSF to expand and push HSPC out of the bone marrow for their efficient 
collection from blood. Indeed, blood obtained from G-CSF-treated donors is nowadays 
the preferred source of HSPC for transplantation therapy.  A surprising side-effect of G-
CSF treatment is the appearance of low-grade fever and bone pain that responds to 
nonsteroid anti-inflammatory drugs (NSAID), which inhibit the prostaglandin synthesis 
pathway. How G-CSF caused fever was unknown, until now. 
While studying the mechanism of fever in experimental models of G-CSF mobilization, 
Kawano et al. identify a previously unknown molecular and cellular circuitry in the bone 
marrow that induces the production of PGE2. This lipid not only caused fever, but also 
limited the inhibitory effect of G-CSF on the hematopoietic niche.  
The authors reasoned that if G-CSF treatment caused a raise in temperature that could 
be prevented by NSAID, activation of the arachidonic acid cascade and production of 
pyrogenic prostaglandin E2 might be involved in the mobilizing effects of the cytokine. 
They identified the microsomal PGE-1 synthase as a critical mediator of fever in G-
CSF-treated mice. Surprisingly, while deficiency in this catalytic enzyme prevented 
changes in body temperature, it enhanced –rather than prevent- mobilization of HSPC 
into blood, and these effects required its expression in the transplantable hematopoietic 
compartment. The authors found, however, that G-CSF did not trigger PGE2 production 
by acting directly on hematopoietic cells. How, then, did G-CSF control prostaglandin 
production? 
To search for possible mechanisms the authors revisited their own seminal work from a 
decade earlier demonstrating that G-CSF stimulates the catecholaminergic tone in the 
bone marrow 4. They therefore predicted that catecholamines might be intermediaries 
needed for PGE2 production. Indeed, treatment with a -adrenergic agonist stimulated 
prostaglandin release by neutrophils, and to a lesser extent by macrophages, in a 
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process that depended on the 3 adrenergic receptor. The authors went on to 
demonstrate that if neutrophils were depleted before G-CSF treatment, or if the cells 
that produce catecholamines were eliminated, then fever disappeared in treated mice.   
These findings, however, were at odds with the exaggerated mobilization of HSPC in 
mice unable to synthesize PGE2, and suggested that generation of fever and 
mobilization were antagonistic effects. The response to this puzzle came, again, after 
revisiting earlier work showing that PGE2 improves HSPC retention by stimulating 
osteoblastic cell function through production of osteopontin, an HSPC retention 
molecule 5. In agreement with these observations, Kawano et al. found that indeed 
PGE2 acts locally in the bone marrow by dramatically increasing osteopontin on pre-
osteoblastic cells, through the prostaglandin receptor EP4. Altogether, the data 
presented in this paper uncovers a signaling network elicited by G-CSF that stimulates 
catecholamine production, which acts on 3-adrenergic receptors on neutrophils to 
induce production of PGE2. This lipid acts locally on niche cells to limit HSPC release, 
and systemically on the hypothalamus to induce fever (see Figure). 
The findings by the Katayama group are important because they provide formal 
demonstration that neutrophils, which are the most abundant cell type in the bone 
marrow, are bona fide regulators of the HSPC niche. Previous studies had 
demonstrated that neutrophils can induce local inhibition of niches, or control 
granulopoiesis from extramedullary tissues 6,7. The present study, however, is the first 
to identify a neutrophil-derived product that positively regulates niche cells. Although 
less abundant, monocytes and macrophages respond in a similar way, thereby 
reinforcing the notion that innate immunity is an important regulatory network within the 
marrow. Different from other proposed niche cells, however, neutrophils and other 
myeloid cells appear to provide a system that better integrates environmental signals 
for finer regulation of HSPC during stress. The study raises the important question of 
whether, and if so how, innate immunity regulates stem cell niches in the context of 
pathological stress (e.g., infection or leukemia).  
Finally, it is intriguing that experimental depletion of neutrophils caused mild but 
significant reductions in body temperature after G-CSF treatment. Because neutrophils 
are distributed in many more organs than the bone marrow, are can themselves 
produce not only PGE2 but also catecholamines 8, it would seem that neutrophils are 
superbly fitted to regulate core processes, as illustrated here for body temperature and 
stem cell niches. Clearly, neutrophils are far more than immune defenders. 
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Treatment with G-CSF causes mobilization of HSPC and triggers fever. By acting on 
catecholaminergic cells (nerve cells or other), G-CSF increases the adrenergic tone in 
the marrow, thereby generating catecholamines that in turn activate neutrophils through 
the 3 adrenergic receptor (3R; inset). As a consequence of adrenergic stimulation 
neutrophils produce PGE2, which can target osteoblastic cells through the EP4  receptor 
to promote HSPC retention. Additionally, neutrophil-derived PGE2 causes fever by 
systemically acting on the brain. 
